Technology News and Research

RSS

Legislation on Assisted Reproductive Technology proposed by the ICMR discussed

Vinay Menon of Mumbai, India-based law firm Menon & Associates (www.menonlawassociates.com) and Indian Counsel for Proactive Family Solutions was among the panel speakers on this topic at the Fall Conference of the American Bar Association Section of Family Law recently held in Montreal, Canada.

29 Oct 2009

Residents can serve a vital role in promoting CT colonography awareness

Residents can serve a vital role in educating Congress, the medical community, and the general public regarding the efficacy of cutting-edge technologies like CT colonography (CTC) as well as the importance of radiologists' training and education and the role that radiologists serve in the provision of quality health care, according to an article published in the November issue of the Journal of the American College of Radiology (JACR).

29 Oct 2009

Sweep Technology, a new way for adjusting hearing aids

Starkey Laboratories, Inc., one of the world’s leading hearing technology companies, is excited to introduce Sweep™ Technology – providing a completely new way to adjust hearing aids.

29 Oct 2009

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a “significant strategy” in the future design of anti-aging pharmaceuticals.

29 Oct 2009

Fresenius Kabi to license its proprietary HESylation Technology to Octapharma

Octapharma Group and Fresenius Kabi have signed a License, Development and Supply Agreement regarding the use of Fresenius Kabi's HESylation® Technology to develop a HESylated recombinant protein.

29 Oct 2009

CNS Protein Therapeutics changes its corporate name to Amarantus Therapeutics

CNS Protein Therapeutics, Inc., a privately held biotechnology company developing first-in-class disease–modifying treatments that address the underlying cause of cell death associated with a wide range of diseases, has completed a corporate name change to Amarantus Therapeutics, Inc. (“Amarantus”) and appointed prominent biotechnology industry executive, Martin D. Cleary, as Chief Executive Officer.

29 Oct 2009

Sangamo BioSciences awarded a grant to develop zinc finger nuclease-based stem cell therapy for AIDS

Sangamo BioSciences, Inc. announced today that the California Institute for Regenerative Medicine (CIRM) has granted a $14.5 million Disease Team Research Award to develop an AIDS-related lymphoma therapy based on the application of its zinc finger nuclease (ZFN) gene-editing technology in stem cells.

29 Oct 2009

Repros Therapeutics amends its existing license for Proellex

Repros Therapeutics today announced that the Company has entered into an amendment with the National Institutes of Health (NIH) to its existing exclusive license for Proellex® that revises the existing milestones and dates for performance to provide additional time to lift the current clinical hold on Proellex or select a second generation molecule for further development from the family of anti-progestational agents covered by the license.

29 Oct 2009

Praxis Version 5 featuring Datum released

Infor-Med Corporation, makers of Praxis Electronic Medical Records (EMR), announced today the beta release of Praxis Version 5 featuring Datum, a tool that allows physicians to use free text to create, store, and share discrete clinical data.

29 Oct 2009

Interpreters at UNC Hospitals carry iPod Touch to stay connected

Pagers are ubiquitous in the hospital setting. They are so familiar and common, in fact, that they are even used for comic effect on medically themed TV dramas such as "House M.D."

29 Oct 2009

AMT inks agreement with Progenika Biopharma for development of LPLchip

Amsterdam Molecular Therapeutics (AMT) and Progenika Biopharma announced today that the companies have entered into a development and commercialization agreement for LPLchip(TM), a diagnostic tool to rapidly diagnose patients with complete and partial lipoprotein lipase deficiency (LPLD). AMT has developed Glybera(R) as a gene therapy for patients with this disease.

29 Oct 2009

CCO HIV inPractice to provide critical information for the management of HIV/AIDS launched

Clinical Care Options (CCO), a leader in the development of innovative online, print, and live medical education programs and medical education technologies for healthcare professionals, announced the launch of CCO HIV inPractice, a new, free, online point-of-care resource for clinicians that provides critical information for the management of HIV/AIDS.

29 Oct 2009

Computer model to track contaminated soil distribution in households

Where does it come from? Scientists in Arizona are reporting a surprising answer to that question, which has puzzled and perplexed generations of men and women confronted with layers of dust on furniture and floors. Most of indoor dust comes from outdoors. Their report is scheduled for the Nov. 1 issue of ACS' Environmental Science & Technology, a semi-monthly journal.

29 Oct 2009

PAIR Technologies to commercialize planar array infrared spectrograph

PAIR Technologies, a start-up company established by University of Delaware researchers and a former DuPont scientist, is preparing to commercialize a high-precision detector -- a planar array infrared spectrograph -- that can identify biological and chemical agents in solids, liquids, and gases, in quantities as small as an atom, and in less than a second.

29 Oct 2009

Nanoparticles from antibacterial textiles could harm fish and other wildlife

Scientists in Switzerland are reporting results of one of the first studies on the release of silver nanoparticles from laundering those anti-odor, anti-bacterial socks now on the market. Their findings, scheduled for the Nov. 1 issue of ACS' journal Environmental Science & Technology, may suggest ways that manufacturers and consumers can minimize the release of these particles to the environment, where they could harm fish and other wildlife.

29 Oct 2009

CCGMP’s new interactive website launched

Content Data Solutions, developers of publishing software, systems integration, and pre-press solutions, and Castle Connolly Graduate Medical Publishing (CCGMP) are pleased to announce the launch of CCGMP’s new interactive website which brings Castle Connolly Graduate’s Medical Board Review Manuals and interactive study tools online.

29 Oct 2009

Biomoda to launch multisite Phase III clinical trials of CyPath assay

Medical diagnostics company Biomoda, Inc. is taking preliminary steps to launch multisite Phase III clinical trials of its in-vitro diagnostic for early-stage lung cancer, trademarked under the name CyPath®.

29 Oct 2009

GE Healthcare to provide surveillance data for H1N1 and seasonal influenza activity throughout the U.S.

GE Healthcare, one of the leading providers of healthcare information technology, today announced its selection by the Centers for Disease Control and Prevention (CDC) to provide extensive surveillance data for H1N1 and seasonal influenza activity throughout the United States.

29 Oct 2009

HD colonoscopy is more sensitive than standard colonoscopy in finding polyps: Study

High-definition (HD) colonoscopy is much more sensitive than standard colonoscopy in finding polyps that could morph into cancer, say researchers at the Mayo Clinic campus in Florida.

29 Oct 2009

Fertility Centers of Illinois offers "baby or money back" program

A new study has confirmed anecdotal reports that the recession has caused a decline in fertility treatments across the country. With price being the major deterrent, the report indicates that assisted reproductive technology (ART) such as In Vitro Fertilization (IVF) is sought mostly by affluent, educated, Caucasian women and forecasts a 5% decline in IVF procedures by the end of 2009.

28 Oct 2009